Laura Alessio
Investitore di Private Equity presso Atlas Venture Advisors, Inc.
Profilo
Laura Alessio joined Atlas in August 2022 as director of portfolio operations.
She is responsible for start-up portfolio formation and business operations, portfolio transitions and various broad portfolio initiatives.
Prior to joining Atlas, Laura was chief of staff at eGenesis, where she was the strategic right-hand person to the CEO, helped determine and drive business planning as well as responsible for program and project management at a tactical, strategic and operational level.
Prior to eGenesis, Laura served as operations manager at Cydan where she was responsible for all day-to-day company operations and was instrumental in incorporating and setting up Cydan rare disease spin-out companies and closing Series A investments.
Laura received a BSBA from Middlesex College and an executive administration degree from the Burdett School of Business.
She also holds certifications in website design, business analytics and investor relations.
Outside of work, Laura enjoys being on the water at Sebago Lake in Maine, spending time with her 3 Boston Terriers and considers herself a “Relic Junkie,” which she named her vintage furniture and décor shop.
Posizioni attive di Laura Alessio
Società | Posizione | Inizio |
---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investitore di Private Equity | 01/08/2022 |
Precedenti posizioni note di Laura Alessio
Società | Posizione | Fine |
---|---|---|
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2022 |
Home Market Foods, Inc.
Home Market Foods, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Home Market Foods, Inc. develops, manufactures, and markets retail packaged and frozen foods. It offers cooked and frozen food, cooked meatballs, cooked bites, value-added meal entrees, appetizers, and snacks. The firm's brands include Cooked Perfect, RollerBites, Bahama Mama, Eisenberg and Cooked Perfect food service. The company was founded in 1957 and is headquartered in Norwood, MA. | Investitore di Private Equity | 01/04/2013 |
Formazione di Laura Alessio
Merrimack College | Undergraduate Degree |
Middlesex Community College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Home Market Foods, Inc.
Home Market Foods, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Home Market Foods, Inc. develops, manufactures, and markets retail packaged and frozen foods. It offers cooked and frozen food, cooked meatballs, cooked bites, value-added meal entrees, appetizers, and snacks. The firm's brands include Cooked Perfect, RollerBites, Bahama Mama, Eisenberg and Cooked Perfect food service. The company was founded in 1957 and is headquartered in Norwood, MA. | Consumer Non-Durables |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Laura Alessio